{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:52:30Z","timestamp":1780372350682,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T00:00:00Z","timestamp":1465948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00223-016-0161-3","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T11:28:25Z","timestamp":1465990105000},"page":"360-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-0755","authenticated-orcid":false,"given":"Giovanni","family":"Adami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Orsolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,15]]},"reference":[{"key":"161_CR1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.61.suppl_2.ii84","volume":"61","author":"EM Gravallese","year":"2002","unstructured":"Gravallese EM (2002) Bone destruction in arthritis. Ann Rheum Dis 61:84\u201386","journal-title":"Ann Rheum Dis"},{"key":"161_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese E (2012) Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol 8:656\u2013664. doi: 10.1038\/nrrheum.2012.153","journal-title":"Nat Rev Rheumatol"},{"key":"161_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TWJ (2010) Rheumatoid arthritis. Lancet Lond Engl 376:1094\u20131108. doi: 10.1016\/S0140-6736(10)60826-4","journal-title":"Rheumatoid arthritis. Lancet Lond Engl"},{"key":"161_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/ar127","volume":"2","author":"S Roux","year":"2000","unstructured":"Roux S, Orcel P (2000) Bone loss. Factors that regulate osteoclast differentiation: an update. Arthritis Res 2:451\u2013456. doi: 10.1186\/ar127","journal-title":"Arthritis Res"},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"728610","DOI":"10.1155\/2015\/728610","volume":"2015","author":"AA Jilani","year":"2015","unstructured":"Jilani AA, Mackworth-Young CG (2015) The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol 2015:728610. doi: 10.1155\/2015\/728610","journal-title":"Int J Rheumatol"},{"key":"161_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163. doi: 10.1038\/nm1538","journal-title":"Nat Med"},{"key":"161_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of WNT\/\u03b2-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121\u2013132. doi: 10.1007\/s00223-013-9749-z","journal-title":"Calcif Tissue Int"},{"key":"161_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3899\/jrheum.100089","volume":"38","author":"S-Y Wang","year":"2011","unstructured":"Wang S-Y, Liu Y-Y, Ye H et al (2011) Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. J Rheumatol 38:821\u2013827. doi: 10.3899\/jrheum.100089","journal-title":"J Rheumatol"},{"key":"161_CR9","first-page":"77","volume":"33","author":"M Rossini","year":"2015","unstructured":"Rossini M, Viapiana O, Adami S et al (2015) In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density. Clin Exp Rheumatol 33:77\u201383","journal-title":"Clin Exp Rheumatol"},{"key":"161_CR10","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/ard.2010.132852","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland GR, Zwerina K, Baum W et al (2010) Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis 69:2152\u20132159. doi: 10.1136\/ard.2010.132852","journal-title":"Ann Rheum Dis"},{"key":"161_CR11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.bbagen.2013.12.013","volume":"1840","author":"S Kotake","year":"2014","unstructured":"Kotake S, Nanke Y (2014) Effect of TNF\u03b1 on osteoblastogenesis from mesenchymal stem cells. Biochim Biophys Acta 1840:1209\u20131213. doi: 10.1016\/j.bbagen.2013.12.013","journal-title":"Biochim Biophys Acta"},{"key":"161_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrrheum.2014.198","volume":"11","author":"IE Adamopoulos","year":"2015","unstructured":"Adamopoulos IE, Mellins ED (2015) Alternative pathways of osteoclastogenesis in inflammatory arthritis. Nat Rev Rheumatol 11:189\u2013194. doi: 10.1038\/nrrheum.2014.198","journal-title":"Nat Rev Rheumatol"},{"key":"161_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588. doi: 10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"key":"161_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"key":"161_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-016-0114-x","author":"G Orsolini","year":"2016","unstructured":"Orsolini G, Adami G, Adami S et al (2016) Short-term effects of TNF inhibitors on bone turnover markers and bone mineral density in rheumatoid arthritis. Calcif Tissue Int. doi: 10.1007\/s00223-016-0114-x","journal-title":"Calcif Tissue Int"},{"key":"161_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3899\/jrheum.120397","volume":"40","author":"A Szentpetery","year":"2013","unstructured":"Szentpetery A, McKenna MJ, Murray BF et al (2013) Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis. J Rheumatol 40:653\u2013662. doi: 10.3899\/jrheum.120397","journal-title":"J Rheumatol"},{"key":"161_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/ard.2005.044198","volume":"65","author":"M Vis","year":"2006","unstructured":"Vis M, Havaardsholm EA, Haugeberg G et al (2006) Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 65:1495\u20131499. doi: 10.1136\/ard.2005.044198","journal-title":"Ann Rheum Dis"},{"key":"161_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3904\/kjim.2014.29.6.807","volume":"29","author":"MJ Lim","year":"2014","unstructured":"Lim MJ, Kwon SR, Joo K et al (2014) Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use. Kor J Intern Med 29:807\u2013813. doi: 10.3904\/kjim.2014.29.6.807","journal-title":"Kor J Intern Med"},{"key":"161_CR19","doi-asserted-by":"publisher","first-page":"e000065","DOI":"10.1136\/rmdopen-2015-000065","volume":"1","author":"M Manara","year":"2015","unstructured":"Manara M, Sinigaglia L (2015) Bone and TNF in rheumatoid arthritis: clinical implications. RMD Open 1:e000065. doi: 10.1136\/rmdopen-2015-000065","journal-title":"RMD Open"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477\u2013501. doi: 10.1210\/edrv.22.4.0437","journal-title":"Endocr Rev"},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"E991","DOI":"10.1210\/jc.2013-3846","volume":"99","author":"MV Augustine","year":"2014","unstructured":"Augustine MV, Leonard MB, Thayu M et al (2014) Changes in vitamin D-related mineral metabolism after induction with anti-tumor necrosis factor-\u03b1 therapy in Crohn\u2019s disease. J Clin Endocrinol Metab 99:E991\u2013E998. doi: 10.1210\/jc.2013-3846","journal-title":"J Clin Endocrinol Metab"},{"key":"161_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s12020-013-9960-8","volume":"44","author":"R Pacifici","year":"2013","unstructured":"Pacifici R (2013) Role of T cells in the modulation of PTH action: physiological and clinical significance. Endocrine 44:576\u2013582. doi: 10.1007\/s12020-013-9960-8","journal-title":"Endocrine"},{"key":"161_CR23","doi-asserted-by":"publisher","first-page":"e12290","DOI":"10.1371\/journal.pone.0012290","volume":"5","author":"H Tawfeek","year":"2010","unstructured":"Tawfeek H, Bedi B, Li J-Y et al (2010) Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PloS One 5:e12290. doi: 10.1371\/journal.pone.0012290","journal-title":"PloS One"},{"key":"161_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00223-012-9665-7","volume":"92","author":"O Viapiana","year":"2013","unstructured":"Viapiana O, Fracassi E, Troplini S et al (2013) Sclerostin and DKK1 in primary hyperparathyroidism. Calcif Tissue Int 92:324\u2013329. doi: 10.1007\/s00223-012-9665-7","journal-title":"Calcif Tissue Int"},{"key":"161_CR25","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jc.2010-2552","volume":"96","author":"D Gatti","year":"2011","unstructured":"Gatti D, Viapiana O, Idolazzi L et al (2011) The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1. J Clin Endocrinol Metab 96:1555\u20131559. doi: 10.1210\/jc.2010-2552","journal-title":"J Clin Endocrinol Metab"},{"key":"161_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1359\/jbmr.090820","volume":"25","author":"J Borggrefe","year":"2010","unstructured":"Borggrefe J, Graeff C, Nickelsen TN et al (2010) Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS study. J Bone Miner Res 25:472\u2013481. doi: 10.1359\/jbmr.090820","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"161_CR27","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3899\/jrheum.080356","volume":"35","author":"P Garnero","year":"2008","unstructured":"Garnero P, Tabassi NC-B, Voorzanger-Rousselot N (2008) Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept. J Rheumatol 35:2313\u20132315","journal-title":"J Rheumatol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0161-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0161-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0161-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:24:00Z","timestamp":1498307040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0161-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,15]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0161-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,15]]}}}